Strong rebound of wakefulness follows prostaglandin D2- or adenosine A(2a) receptor agonist-induced sleep

Journal of Sleep Research

Volumn 9, Issue 1, 2000, Pages 81-87

  Gerashchenko, Dmitry ^a   Okano, Yasuhisa ^b   Urade, Yoshihiro ^a,c   Inoué, Shojiro ^b   Hayaishi, Osamu ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

CGS21680; Paradoxical sleep; Prostaglandin D2; Slow wave sleep; Wakefulness rebound

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR AGONIST; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG INFUSION; INSOMNIA; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SLEEP INDUCTION; SLOW WAVE SLEEP; WAKEFULNESS;

ADENOSINE; ANIMALS; MALE; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PURINERGIC P1; SLEEP, REM; TIME FACTORS; WAKEFULNESS;

EID: 0034115163     PISSN: 09621105     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2869.2000.00175.x     Document Type: Article

References (26)

1. Borbély, A. A. A two process model of sleep regulation. Hum. Neurobiol., 1982, 1: 195-204.
2. 2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A. Mol. Pharmacol., 1995, 48: 1-8.
3. 2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol. Pharmacol., 1993, 44: 950-958.
4. Cooper, B., Schafer, A. I., Puchalsky, D. and Handin, R. I. Desensitization of prostaglandin-activated platelet adenylate cyclase. Prostaglandins, 1979, 17: 561-571.
5. Daan, S., Beersma, D. G. and Borbély, A. A. Timing of human sleep: recovery process gated by a circadian pacemaker. Am. J. Physiol., 1984, 246 (2 part 2): R161-183.
6. Gerashchenko, D. and Matsumura, H. Continuous recordings of brain regional circulation during sleep/wake state transitions in rats. Am. J. Physiol., 1996, 270 (4 part 2): R855-863.
7. 2. FASEB J., 1991, 5: 2575-2581.
8. Huston. J. P., Haas, H. L., Boix, F., Pfister, M., Decking, U., Schrader, J. and Schwarting, R. K. Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats. Neuroscience, 1996, 73: 99-107.
9. 2 on the activity of hypothalamic neurons in the rat. Jpn. J. Physiol., 1986, 36: 497-509.
10. Janusz, C. A. and Berman, R. F. The A2-selective adenosine analog, CGS 21680. depresses locomotor activity but does not block amygdala kindled seizures in rats. Neurosci. Lett., 1992, 141:247-250.
11. Kales, A., Bixler, E. O., Tan, T. L., Scharf, M. B. and Kales, J. D. Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependence. JAMA, 1974, 227: 513-517.
12. 2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. Natl. Acad. Sci. USA, 1994, 91: 11998-12002.
13. 2 in freely moving rats. Brain Res., 1989, 481: 242-249.
14. Merlotti, L., Roehrs, T., Zorick, F. and Roth, T. Rebound insomnia: duration of use and individual differences. J. Clin. Psychopharmacol., 1991, 11: 368-373.
15. 2 receptors in human platelets. J. Pharmacol. Exp. Ther., 1979, 210: 134-140.
16. 2 exerts an awaking effect in the posterior hypothalamus at a site distinct from that mediating its febrile action in the anterior hypothalamus. J. Neurosci., 1992, 12: 2715-2725.
17. 2a adenosine receptor: delineation of multiple processes. Mol. Pharmacol., 1994, 45: 1082-1094.
18. 2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats. Biochem. Mol. Biol. Int., 1995, 37: 431-437.
19. Paxinos, G. and Watson, C. The Rat Brain in Stereotaxic Coordinates. Academic, San Diego. 1986.
20. Portas, C. M., Thakkar, M., Rainnie, D. G., Greene, R. W. and McCarley, R. W. Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience, 1997, 79: 225-235.
21. Radulovacki, M., Virus, R. M., Djuricic-Nedelson, M. and Green, R. D. Hypnotic effects of deoxycoformycin in rats. Brain Res., 1983, 271: 392-395.
22. 2, are correlated with increasing propensity towards sleep in rats. Brain Res., 1997, 751: 81-89.
23. Roehrs, T., Merlotti, L., Zorick, F. and Roth, T. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. Psychopharmacology, 1992, 108: 67-71.
24. 2 in rats. Proc. Natl. Acad. Sci. U S A, 1996, 93: 5980-5984.
25. Seidel, W. F., Maze, M., Dement, W. C. and Edgar, D. M. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat. J. Pharmacol. Exp. Ther., 1995, 275: 263-273.
26. 2-sensitive sleep-promoting zone in the rat brain. J. Neurosci., 1998, 18: 6599-6607.